The dosages below are from completed studies on humans or on clinical trials on humans. In general, they represent safe dosages for most people. Please be aware that there is often an exponentail effectiveness. Talking half the dosage may only see 1/4 of the effect. We are not looking at minimum effective dosage, but maximum [safe] dosage used in clinical trials and studies.
If a study has been completed, the dosage will be marked Ineffective or Effective -- depending if statistically changes were reported by the study.
This is not medical advice (see your MD for that). It is a reporting on dosages that some MDs have used.
Study | Clinical Study | Dosage | Effective |
---|---|---|---|
๐ Study | 2 mg/day | Effective | |
๐ Study | 100 mcg/day |
|
|
๐ Study | 500 µg/day |
|
|
. | Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients | 360 mcg/day | |
. | Vitamin K Supplementation Study in Healthy Volunteers (Aim 2B) | 1 mg/day | |
๐ Study | 500 mcg/day | Effective | |
. | Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19 (KOVIT) | 999 mcg/day |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2022 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.